Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLUORESCEIN vs INDIGOTINDISULFONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FLUORESCEIN vs INDIGOTINDISULFONATE: Safety Overview

Metric FLUORESCEIN INDIGOTINDISULFONATE
Total FAERS Reports 588 20
Deaths Reported 31 0
Death Rate 5.3% N/A
Hospitalizations 134 6
Average Patient Age 55.2 yrs 52.9 yrs
% Female Patients 51.1% 76.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Jul 8, 2022
Manufacturer Nomax Inc. Provepharm Inc.
Route OPHTHALMIC INTRAVENOUS
Marketing Status Discontinued Prescription